Literature DB >> 12213724

Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma (Richter's syndrome).

Sílvia Beà1, Armando López-Guillermo, Maria Ribas, Xavier Puig, Magda Pinyol, Ana Carrió, Lurdes Zamora, Francesc Soler, Francesc Bosch, Stephan Stilgenbauer, Dolors Colomer, Rosa Miró, Emili Montserrat, Elias Campo.   

Abstract

Chromosomal imbalances were examined by comparative genomic hybridization in 30 cases of B-cell chronic lymphocytic leukemia (CLL) at diagnosis, in sequential samples from 17 of these patients, and in 6 large B-cell lymphomas transformed from CLL [Richter's syndrome (RS)] with no available previous sample. The most common imbalances in CLL at diagnosis were gains in chromosome 12 (30%), and losses in chromosomes 13 (17%), 17p (17%), 8p (7%), 11q (7%), and 14q (7%). The analysis of sequential samples showed an increased number of chromosomal imbalances in 6 of 10 (60%) patients with clinical progression and in 2 patients with stable stage C disease. No karyotypic evolution was observed in four cases with stable stage A disease and in one RS clonally unrelated to the previous CLL. Gains of 2pter, and 7pter, and losses of 8p, 11q, and 17p were recurrent alterations associated with karyotype progression. RS showed a higher number of gains, losses, total alterations, and losses of 8p and chromosome 9 than CLL at diagnosis. 17p losses were associated with p53 gene mutations and with a significantly higher number of chromosomal imbalances than tumors with normal chromosome 17 profile. However, no relationship was observed between 9p deletions and p16(INK4a) gene alterations. Losses of 17p and an increased number of losses at diagnosis were significantly associated with a shorter survival. These findings indicate that CLL has frequent chromosomal imbalances, which may increase during the progression of the disease and transformation into large cell lymphoma. Genetic alterations detected by comparative genomic hybridization may also be of prognostic significance.

Entities:  

Mesh:

Year:  2002        PMID: 12213724      PMCID: PMC1867253          DOI: 10.1016/S0002-9440(10)64256-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  40 in total

1.  Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: a simple and sensitive method.

Authors:  J Anastasi; M M Le Beau; J W Vardiman; A A Fernald; R A Larson; J D Rowley
Journal:  Blood       Date:  1992-04-01       Impact factor: 22.113

2.  Mutations of the p53 gene in B-cell chronic lymphocytic leukemia: a report on 39 cases with cytogenetic analysis.

Authors:  P Fenaux; C Preudhomme; J L Laï; I Quiquandon; P Jonveaux; M Vanrumbeke; C Sartiaux; P Morel; M H Loucheux-Lefebvre; F Bauters
Journal:  Leukemia       Date:  1992-04       Impact factor: 11.528

3.  p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.

Authors:  G Gaidano; P Ballerini; J Z Gong; G Inghirami; A Neri; E W Newcomb; I T Magrath; D M Knowles; R Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

4.  Karyotypic stability in chronic B-cell leukemia.

Authors:  P C Nowell; L Moreau; P Growney; E C Besa
Journal:  Cancer Genet Cytogenet       Date:  1988-07-15

5.  Richter's syndrome with identification of marker chromosomes.

Authors:  P H Fitzgerald; C M McEwan; J W Hamer; M E Beard
Journal:  Cancer       Date:  1980-07-01       Impact factor: 6.860

6.  Karyotypic evolution in B-cell chronic lymphocytic leukaemia.

Authors:  D Oscier; M Fitchett; T Herbert; R Lambert
Journal:  Genes Chromosomes Cancer       Date:  1991-01       Impact factor: 5.006

7.  Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants.

Authors:  S Beà; M Ribas; J M Hernández; F Bosch; M Pinyol; L Hernández; J L García; T Flores; M González; A López-Guillermo; M A Piris; A Cardesa; E Montserrat; R Miró; E Campo
Journal:  Blood       Date:  1999-06-15       Impact factor: 22.113

8.  Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities.

Authors:  G Juliusson; D G Oscier; M Fitchett; F M Ross; G Stockdill; M J Mackie; A C Parker; G L Castoldi; A Guneo; S Knuutila; E Elonen; G Gahrton
Journal:  N Engl J Med       Date:  1990-09-13       Impact factor: 91.245

9.  Consistency of chromosomal aberrations in chronic B-lymphocytic leukemia. A longitudinal cytogenetic study of 41 patients.

Authors:  G Juliusson; K Friberg; G Gahrton
Journal:  Cancer       Date:  1988-08-01       Impact factor: 6.860

10.  Cytogenetic evidence for clonal evolution in B-cell chronic lymphocytic leukemia.

Authors:  T Han; K Ohtaki; N Sadamori; A W Block; B Dadey; H Ozer; A A Sandberg
Journal:  Cancer Genet Cytogenet       Date:  1986-12
View more
  15 in total

1.  Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations.

Authors:  Carsten Schwaenen; Michelle Nessling; Swen Wessendorf; Tatjana Salvi; Gunnar Wrobel; Bernhard Radlwimmer; Hans A Kestler; Christian Haslinger; Stephan Stilgenbauer; Hartmut Döhner; Martin Bentz; Peter Lichter
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-16       Impact factor: 11.205

2.  Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior.

Authors:  Eva Giné; Antoni Martinez; Neus Villamor; Armando López-Guillermo; Mireia Camos; Daniel Martinez; Jordi Esteve; Xavier Calvo; Ana Muntañola; Pau Abrisqueta; Maria Rozman; Ciril Rozman; Francesc Bosch; Elias Campo; Emili Montserrat
Journal:  Haematologica       Date:  2010-04-26       Impact factor: 9.941

3.  Precursor B cell lymphoid blast crisis of chronic myeloid leukemia with novel chromosomal abnormalities: A case report.

Authors:  Hamoud Al-Khallaf; Hani Alali; Adil Alkhatti
Journal:  Oncol Lett       Date:  2018-09-25       Impact factor: 2.967

Review 4.  Molecular pathogenesis of CLL and its evolution.

Authors:  David Rodríguez; Gabriel Bretones; Javier R Arango; Víctor Valdespino; Elías Campo; Víctor Quesada; Carlos López-Otín
Journal:  Int J Hematol       Date:  2015-01-29       Impact factor: 2.490

5.  Gain in the short arm of chromosome 2 (2p+) induces gene overexpression and drug resistance in chronic lymphocytic leukemia: analysis of the central role of XPO1.

Authors:  A Cosson; E Chapiro; N Bougacha; J Lambert; L Herbi; H-A Cung; C Algrin; B Keren; F Damm; C Gabillaud; M-N Brunelle-Navas; F Davi; H Merle-Béral; M Le Garff-Tavernier; D Roos-Weil; S Choquet; M Uzunov; V Morel; V Leblond; K Maloum; S Lepretre; P Feugier; C Lesty; J Lejeune; L Sutton; Y Landesman; S A Susin; F Nguyen-Khac
Journal:  Leukemia       Date:  2017-03-27       Impact factor: 11.528

Review 6.  Evolving understanding of the CLL genome.

Authors:  Michaela Gruber; Catherine J Wu
Journal:  Semin Hematol       Date:  2014-05-15       Impact factor: 3.851

Review 7.  Chromosome abnormalities with prognostic impact in B-cell chronic lymphocytic leukemia.

Authors:  Gábor Méhes
Journal:  Pathol Oncol Res       Date:  2005-12-31       Impact factor: 3.201

8.  Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature.

Authors:  Itziar Salaverria; Andreas Zettl; Sílvia Beà; Victor Moreno; Joan Valls; Elena Hartmann; German Ott; George Wright; Armando Lopez-Guillermo; Wing C Chan; Dennis D Weisenburger; Randy D Gascoyne; Thomas M Grogan; Jan Delabie; Elaine S Jaffe; Emili Montserrat; Hans-Konrad Muller-Hermelink; Louis M Staudt; Andreas Rosenwald; Elias Campo
Journal:  J Clin Oncol       Date:  2007-02-12       Impact factor: 44.544

9.  Composite small lymphocytic lymphoma and extra-medullary myeloid tumor: a potential diagnostic pitfall.

Authors:  Shiyong Li; Karen P Mann; Jeannine T Holden
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

10.  Induction of aneuploidy by increasing chromosomal instability during dedifferentiation of hepatocellular carcinoma.

Authors:  Ludwig Wilkens; Peer Flemming; Michael Gebel; Joerg Bleck; Christof Terkamp; Luzie Wingen; Hans Kreipe; Brigitte Schlegelberger
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.